ScreenerHero
DXRXDiaceutics PLC
LSE · GB · Healthcare · Health Information Services · diaceutics.com
142.00GBP+3.65%Mkt Cap: 148.71M $P/E: Infinity

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for pr…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
CERT
Certara, Inc.
$1.28BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
PHR
Phreesia, Inc.
$738.82MUSDP/E 74.8

Key Statistics

Company
Market Cap148.71M $
Enterprise Value140.82M $
Revenue (TTM)49.30M $
Gross Profit40.38M $
Net Income (TTM)124.41K $
Revenue/Share0.5823 USD
Last Price142.00 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees205
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)Infinity
P/E (Forward)34.02
PEG—
EV/EBITDA26.88
EV/Revenue2.86
P/S3.04
P/B2.89
EPS (TTM)0.00
EPS (Forward)0.04
52W Range
0.000079% of range180.00
52W High180.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin81.90%
Oper. Margin13.50%
EBITDA Margin10.63%
Profit Margin0.25%
ROE0.24%
ROA0.19%
Growth
Revenue Growth20.30%
Earnings Growth179.90%
Cash Flow & Leverage
Operating CF1.51M $
CapEx (TTM)8.27M $
FCF Margin-10.62%
FCF Yield-3.52%
Net Debt-7.94M $
Net Debt/EBITDA-1.52
Balance Sheet
Debt/Equity0.03
Current Ratio3.43
Quick Ratio3.30
Book Value/Sh0.4780 GBP
Cash/Share0.0870 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)213.00 GBP
Upside (mean)+50.0%
Target Range185.00 GBP – 235.00 GBP
GBP185.00+50.0% to meanGBP235.00
# Analysts5
Ownership
Shares Out.84.63M
Float48.77M
Insiders27.84%
Institutions64.21%
Technical
SMA 50141.87 (+0.1%)
SMA 200150.99 (-6.0%)
Beta0.89
S&P 52W Chg18.16%
Avg Vol (30d)229.16K
Avg Vol (10d)76.54K
Technical Indicators
RSI (14)42.9
MACD0.6421
MACD Signal0.8400
MACD Hist.-0.1979
BB Upper156.94 GBP
BB Middle140.13 GBP
BB Lower123.33 GBP
BB Width23.98%
ATR (14)5.469 GBP
Vol Ratio (20d)0.11x